The 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer listed TERT, alone or in combination with BRAF, as potentially helpful to risk stratify patients in conjunction with other clinicopathological risk factors. This evidence concerns the gene TERT and thyroid gland disorder.